Justin Petrone

1 week ago | 360dx.com | Justin Petrone

NEW YORK – OncoHost, an Israeli biotechnology company, is working with three European medical centers to produce a new flow cytometry test to predict patient response to immunotherapies for five cancer indications, according to Michal Harel, OncoHost's vice president of translational medicine.

2 weeks ago | 360dx.com | Justin Petrone

NEW YORK – A team led by investigators at Institut Pasteur has commenced work on a new lateral flow assay that could be used to detect the presence of the malaria-causing parasite Plasmodium vivax in hard to diagnose, asymptomatic individuals. The project, called PvSeroRDT (short for P. vivax Sero (as in blood) RDT, rapid diagnostic test), received €4 million ($4.5 million) from the EU earlier this year and will run through 2030.

3 weeks ago | 360dx.com | Justin Petrone

NEW YORK – Following a recent $4.3 million financing, Upfront Diagnostics will use the proceeds to accelerate the commercialization of its lateral flow test for triaging stroke patients, LVOne, in the UK, Europe, and US, according to its CEO Gonzalo Ladreda. The Cambridge, UK-based company announced this week that it had raised the funds with Phoenix Investments, a UK investment management fund, leading the round along with Cambridge Enterprise Ventures and SBRI Healthcare.

1 month ago | 360dx.com | Justin Petrone

NEW YORK – Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR) in a bid to support the continued use of laboratory-developed tests. The associations, which represent geneticists, pathologists, physicians and medical laboratories, issued a statement last month, which called for several changes to the IVDR.

1 month ago | precisionmedicineonline.com | Justin Petrone

NEW YORK – Researchers in Ireland have commenced a five-year project to introduce whole-genome sequencing into pediatric cancer care. The aims of the Molecular and Genomic Interrogation of Childhood Cancer-Ireland (MAGIC-I) project are manifold and include gaining better insight into disease development as well as testing out personalized treatment approaches.